Toxoplasmosis in Cats and Zoonotic Risk

Etiology and Life Cycle

Toxoplasmosis is caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. The felid family, particularly the domestic cat, serves as the definitive host in which sexual reproduction occurs [1]. The asexual cycle can occur in all warm-blooded intermediate hosts, including humans, livestock, and wildlife [2]. In the feline intestinal tract, T. gondii undergoes a complex life cycle: ingestion of tissue cysts leads to excystation, followed by asexual proliferation (merogony) and then gametogony, culminating in oocyst shedding [3]. A single-cell atlas of T. gondii sexual development in the feline intestinal tract has detailed the transcriptional programs driving these stages [3]. Oocysts are shed in the feces, sporulate within 1–5 days, and become environmentally resistant oocysts capable of surviving months under moderate conditions [3, 4]. The entero-epithelial stage is critical for transmission, and recent work has identified MIC17A as a potential marker for both entero-epithelial and chronic stage infections in cats [5].

Sexual commitment is initiated by proliferative pre-sexual stages characterized by distinct cell division patterns [1]. The feline host responds with dynamic microRNA expression in the small intestine, particularly during the acute phase of infection [4]. Understanding these molecular interactions is essential for developing targeted interventions.

Epidemiology

T. gondii infection is widespread among domestic cats globally. Seroprevalence studies demonstrate remarkable geographic and environmental variability. In Hong Kong, seroprevalence in privately-owned cats and community cats was reported with associated demographic factors [6]. In Jordan, the first seroprevalence and molecular detection of toxoplasmosis in cats cited owner location and outdoor access as risk factors [7]. Stray cats in Bangkok Metropolitan, Thailand, showed T. gondii DNA in feces via PCR, underscoring the role of free-roaming populations in environmental contamination [8]. In Brazil, seroprevalence in dogs, domestic, and companion animals inhabiting urban informal settlements was high, with environmental degradation linked to exposure [9]. Similarly, social marginalisation and environmental degradation were associated with T. gondii exposure in humans in Brazilian urban informal settlements [10].

Seroprevalence is not limited to cats; it extends to veterinary medicine professionals and students, who may be at occupational risk [11]. In Aguascalientes, Mexico, seroprevalence in this group underlined the importance of protective measures [11]. Among livestock, goats in Nigerian quarantine facilities and institutional farms exhibited significant seroprevalence, with risk factors including management practices [12]. Dairy cattle in Eastern Anatolia, Turkey, also demonstrated seropositivity and associated risk factors [13]. In pigs from eastern Spain, low seroprevalence was found in intensive farms where animal entry is controlled [14]. In wildlife, deer in Erbil, Iraq, showed seropositivity for both T. gondii and Neospora caninum [15]. A study in Trishal, Bangladesh, determined genotype distribution and risk factors across multiple animal species, reinforcing the ubiquity of the parasite [16].

The role of cats as shedders of oocysts is central to zoonotic transmission. Fecal samples from stray cats in Thailand yielded molecular evidence of infection, confirming ongoing environmental contamination [8]. In Jordan, molecular detection in cat feces further emphasized the risk [7]. In cats enrolled in a municipal neutering program, T. gondii was detected in reproductive tissues, indicating vertical transmission potential [17]. An aborted equine fetus in Brazil was found positive by molecular methods, with serological evidence in mares enrolled in embryo transfer programs [18]. Similar findings were reported in aborted goat fetuses in Algeria [19].

Clinical Signs and Pathology

Most acute infections in cats are subclinical. However, clinical toxoplasmosis can manifest as ocular, respiratory, hepatic, or neurological disease. Neurological symptoms include ataxia, seizures, and behavioral changes, and have been associated with parasitic manipulation of host behavior [2]. Ocular toxoplasmosis can cause uveitis and retinitis [20]. In immunocompromised animals, disseminated disease may occur. Cerebral toxoplasmosis has been documented in renal transplant recipients in human medicine, illustrating the severe consequences in immunocompromised hosts [21]. In cats, the severity of clinical signs depends on the strain, route of infection, and host immune status [2].

Pathologically, T. gondii causes necrotic and inflammatory lesions in target organs. In the small intestine, enteritis may be observed during entero-epithelial replication [3]. In ocular disease, the posterior segment is most affected [20]. Molecular mechanisms of tissue tropism involve parasite kinases and host cell invasion machinery, with recent advances in vaccine development targeting these pathways [22, 23].

Diagnostics

Accurate diagnosis of feline toxoplasmosis is critical for both clinical management and zoonotic risk assessment. Diagnostic methods include serological, molecular, and antigen detection techniques. The table below summarizes the main approaches with associated references.

Serological tests are widely used. A double-antigen sandwich colloidal gold immunochromatographic strip was developed and field-validated for detecting T. gondii antibodies across multiple host species, including cats, dogs, and pigs [24]. Similarly, a SAG1-based immunochromatographic strip was developed for swine but is adaptable for feline serosurveillance [25]. MIC17A has been explored as a marker for detecting both entero-epithelial and chronic-stage infections in cats via serology [5].

Molecular detection offers high sensitivity. An antisense PCR assay targeting parasite RNA was developed and evaluated for domestic cats, demonstrating improved sensitivity over conventional DNA-based PCR for active infections [26]. Fecal PCR is particularly useful for identifying shedding cats and assessing environmental contamination risk [8, 7].

Treatment and Control

Treatment of clinical toxoplasmosis in cats typically involves clindamycin, either alone or in combination with other antiprotozoals such as trimethoprim-sulfonamide combinations. Supportive care is essential for severe cases. However, no drug can eliminate the chronic tissue cyst stage. Recently, gene-edited live-attenuated vaccines have shown promise in inducing protective immunity in animal models [22]. Advances in T. gondii vaccine development, including mRNA vaccines and One Health strategies, are under investigation [23]. In cats, vaccination could reduce oocyst shedding and thus interrupt the zoonotic cycle, though no commercial vaccine for cats is currently available.

Control measures focus on reducing environmental contamination with oocysts. Litter boxes should be cleaned daily (before sporulation), and feces should be disposed of in sealed bags. Cats should be kept indoors to prevent hunting of intermediate hosts (rodents, birds). Feeding only cooked or commercial food avoids ingestion of tissue cysts [27]. In households with pregnant women or immunocompromised individuals, these measures are crucial.

Zoonotic Risk and One Health Implications

Cat Toxoplasmosis Baby

The zoonotic risk of toxoplasmosis is predominantly associated with ingestion of sporulated oocysts from cat feces or consumption of undercooked meat containing tissue cysts. The phrase "cat toxoplasmosis baby" reflects the heightened concern for congenital infection when a pregnant woman acquires a primary infection [27, 28]. In seronegative pregnant women, seroconversion during gestation can lead to transplacental transmission, resulting in fetal anomalies such as hydrocephalus, chorioretinitis, and intracerebral calcifications [27]. Advice given to seronegative pregnant women who own cats includes strict litter box hygiene, avoidance of stray cats, and cooking meat thoroughly [27]. Studies have evaluated knowledge and practices towards toxoplasmosis among pregnant women in various settings, including Côte d'Ivoire and Erbil, Iraq, revealing significant knowledge gaps that require educational interventions [28, 29].

Other at-risk groups include immunocompromised individuals, such as organ transplant recipients [21] and those with sickle cell disease [30]. In renal transplant recipients, cerebral toxoplasmosis is a rare but severe complication [21]. Seroprevalence among sickle cell disease patients was associated with blood transfusion history [30]. Ocular toxoplasmosis in adults can result from reactivation of congenital or postnatal infections [20].

Behavioral Effects and Parasite Manipulation

A growing body of research suggests that T. gondii infection can alter host behavior, increasing risk-taking in rodents and possibly in humans [2]. In cats, the parasite's manipulation of behavior may increase predation, aiding transmission [2]. These behavioral effects have implications for public health and veterinary care.

One Health Surveillance

Toxoplasmosis exemplifies the interconnectedness of human, animal, and environmental health. Seroprevalence studies in cats and other animals provide vital data for human risk mapping [10, 9]. In urban informal settlements in Brazil, both human and animal seroprevalence were linked to environmental degradation [10, 9]. One Health approaches integrating molecular diagnostics, vaccine development, and public education are essential for effective control [23].

Diagnostic Decision Tree

A diagnostic algorithm for suspected feline toxoplasmosis is presented below, integrating serology and molecular methods.

graph TD
    A[Clinical suspicion: ocular, neurological, respiratory signs], > B{Serology: IgG and IgM}
    B, > |IgG+ IgM-| C[Chronic/latent infection: rule out other causes]
    B, > |IgG- IgM+| D[Recent acute infection]
    B, > |IgG+ IgM+| D
    D, > E[Confirm with PCR on blood or feces]
    E, > F[PCR positive: active infection or shedding]
    E, > G[PCR negative: possible early infection; repeat in 2 weeks]
    F, > H[Assess shedding risk: use fecal PCR or bioassay]
    H, > I[Shedding: institute hygiene measures]
    H, > J[Non-shedding: treat if clinical signs present]

Seroprevalence Comparisons Across Populations

The table below collates select seroprevalence figures from the referenced studies to illustrate global variation.

Pathogenesis and Host-Parasite Interactions

At the cellular level, T. gondii tachyzoites actively invade host cells using a glideosome complex and secrete rhoptry and microneme proteins. The parasite establishes a parasitophorous vacuole that resists fusion with lysosomes. In the definitive host, entero-epithelial stages trigger mucosal immune responses [4]. Pre-sexual stages undergo distinctive cell division characterized by asynchronous nuclear division [1]. A single-cell atlas of sexual development identified novel transcripts expressed specifically in the feline intestine, providing targets for blocking transmission [3].

Conclusion

Toxoplasmosis remains a significant zoonosis with the domestic cat at the center of environmental contamination. Comprehensive understanding of the parasite's life cycle, epidemiology, clinical manifestations, and diagnostic options is essential for veterinarians and public health officials. Prevention of cat toxoplasmosis baby risk requires education of pregnant women and immunocompromised individuals about hygiene and husbandry [28, 29, 27]. Advances in molecular diagnostics and vaccine development offer hope for better control [22, 23, 26]. One Health surveillance networks that integrate data from cats, livestock, wildlife, and humans are critical for mitigating zoonotic risk [10, 23, 9].

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

References

[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/

[2] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41481062/

[3] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/

[4] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/

[5] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/

[6] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[7] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/

[8] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/

[9] Bazan L, Argibay HD, Borges-Silva W, et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41401226/

[10] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330015/

[11] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/

[12] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/

[13] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819961/

[14] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741032/

[15] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034957/

[16] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41528989/

[17] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651631/

[18] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252005/

[19] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864556/

[20] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41603939/

[21] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/

[22] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252477/

[23] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/

[24] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253330/

[25] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/

[26] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/

[27] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/

[28] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/

[29] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41873025/

[30] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931585/

[31] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/

[32] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/

[33] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41643571/

[34] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41597614/

[35] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41471183/